Clinical trials have not reported serious side effects at doses up to 1,000 mg per day
[DOI] [PubMed] [Google Scholar] 108.Wakabayashi K., Yoshimoto M., Tsuji S., Takahashi H
The GHK-Cu Rx Protocol from PlexusDx is a compounded copper-binding tripeptide prescribed by a licensed provider as a pharmacy-grade topical cream
Immaturity of the developing CNS, a larger head-to-body ratio, thinner cranial bones, reduced development of neck and shoulder musculature, a larger subarachnoid space in which the brain can move, and differences in cerebral blood volume have been proposed as possible sources of increased susceptibility to concussions for youth relative to adults (Karlin, 2011
Omaveloxolone was approved in February 2023 in the USA for the treatment of Friedreich's ataxia in adults and adolescents aged 16 years and older
RRL 1 , 1600019 (2017)